Effect of alcohol abuse on selected markers of inflammation, hemostasis, and endothelial function
Abstract
Background: Alcohol consumption, even in moderate amounts, is associated with complex changes in blood biochemistry, involving abnormalities of many markers affecting cardiovascular risk.
Methods: A total of 100 patients with documented alcohol abuse were included in the study. Demographic data and information on alcohol consumption were collected using a standardized questionnaire. All patients underwent biochemical tests. The following parameters were evaluated: PAI-1, vWF, TNF-α, VCAM-1, adiponectin, fibrinogen, lipid profile, and hsCRP. The results were compared with a control group of 25 healthy subjects.
Results: A significant adverse effect of alcohol abuse was observed for markers such as PAI-1, TNF-α, VCAM-1, adiponectin, and fibrinogen. Moreover, most of the subjects showed elevated TC, LDL-C, and TG levels. There was a significant relationship between vWF and average daily alcohol consumption, a positive relationship between adiponectin levels and age, and between fibrinogen and the number of cigarettes smoked. No significant correlations were observed between the other markers and age, gender, place of residence, daily alcohol consumption, and total time of alcohol abuse.
Conclusions: Several abnormalities in most of the analyzed markers were observed in persons abusing alcohol, with no significant correlation with the daily amount of alcohol consumed and the total time of alcohol abuse, which may indicate permanent and irreversible damage to many tissues and organs as a result of chronic alcohol consumption. Further studies in this area with a larger group of patients are necessary to clarify the mechanisms leading to cardiovascular damage in the course of alcohol abuse.
Keywords: alcohol abusecardiovascular diseasecholesterolendothelial functioninflammatory markershemostatic markers
References
- Berdzuli N, Ferreira-Borges C, Gual A, et al. Alcohol Control Policy in Europe: Overview and Exemplary Countries. Int J Environ Res Public Health. 2020; 17(21).
- Visseren FLJ, Mach F, Smulders YM, et al. ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227–3337.
- Wood AM, Kaptoge S, Butterworth AS, et al. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018; 391(10129): 1513–1523.
- Whitman IR, Agarwal V, Nah G, et al. Alcohol Abuse and Cardiac Disease. J Am Coll Cardiol. 2017; 69(1): 13–24.
- Millwood IY, Walters RG, Mei XW, et al. China Kadoorie Biobank Collaborative Group. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019; 393(10183): 1831–1842.
- Stettler G, Moore E, Nunns G, et al. Do not drink and lyse: alcohol intoxication increases fibrinolysis shutdown in injured patients. European Journal of Trauma and Emergency Surgery. 2020; 47(6): 1827–1835.
- van de Wiel A, van Golde PM, Kraaijenhagen RJ, et al. Acute inhibitory effect of alcohol on fibrinolysis. Eur J Clin Invest. 2001; 31(2): 164–170.
- Di Gennaro C, Biggi A, Barilli AL, et al. Endothelial dysfunction and cardiovascular risk profile in long-term withdrawing alcoholics. J Hypertens. 2007; 25(2): 367–373.
- Sacanella E, Badía E, Nicolás JM, et al. Differential effects of moderate or heavy alcohol consumption on circulating adhesion molecule levels. Thromb Haemost. 2002; 88(1): 52–55.
- Capurso NA, Petrakis I. Dyslipidemia associated with heavy alcohol use. Am J Addict. 2016; 25(3): 188–190.
- You M, Arteel GE. Effect of ethanol on lipid metabolism. J Hepatol. 2019; 70(2): 237–248.
- Beulens JWJ, de Zoete EC, Kok FJ, et al. Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr. 2008; 62(9): 1098–1105.
- Englund Ogge L, Brohall G, Behre CJ, et al. Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care. 2006; 29(4): 908–913.
- Imhof A, Plamper I, Maier S, et al. Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care. 2009; 32(6): 1101-1103, doi: 10. 2337/dc08-1723, indexed in Pubmed. ; 19244090.
- Mennen LI, Balkau B, Vol S, et al. Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol. 1999; 19(4): 887–892.
- Eapen CE, Tiwari P, Prasanna KS, et al. Von-Willebrand factor: A biomarker to predict in-hospital survival in patients with severe and very severe alcoholic hepatitis. Current Medical Issues. 2020; 18(3): 158.
- Prasanna KS, Goel A, Amirtharaj GJ, et al. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure. Indian J Gastroenterol. 2016; 35(6): 432–440.
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9): 1135–1143.
- Imhof A, Froehlich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001; 357(9258): 763–767.
- Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003; 107(3): 443–447.
- Gonzalez-Quintela A, Campos J, Loidi L, et al. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol. 2008; 42(6): 513–518.
- Auguet T, Vidal F, López-Dupla M, et al. A study on the TNF-alpha system in Caucasian Spanish patients with alcoholic liver disease. Drug Alcohol Depend. 2008; 92(1-3): 91–99.
- Xia Y, Yang J, Sanyal AJ, et al. Persistent Hyperactivation of Endothelial Cells in Patients with Alcoholic Hepatitis. Alcohol Clin Exp Res. 2020; 44(5): 1075–1087.
- Huang S, Li J, Shearer GC, et al. Longitudinal study of alcohol consumption and HDL concentrations: a community-based study. Am J Clin Nutr. 2017; 105(4): 905–912.
- Hao G, Wang Z, Zhang L, et al. Relationship Between Alcohol Consumption and Serum Lipid Profiles Among Middle-Aged Population in China: A Multiple-Center Cardiovascular Epidemiological Study. Angiology. 2015; 66(8): 753–758.
- Kwon YJ, Kim SE, Park BJ, et al. High-risk drinking is associated with dyslipidemia in a different way, based on the 2010-2012 KNHANES. Clin Chim Acta. 2016; 456: 170–175.
- Bastard JP, Maachi, M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw . 206; 17(1): 4–12.
